AMO/Quest pact for accommodating IOLs
This article was originally published in The Gray Sheet
Executive Summary
R&D and licensing agreement gives Advanced Medical Optics one year to evaluate Quest Vision Technologies' FocusIOL and FlexOptic accommodating intra-ocular lens technology for presbyopia, a minority stake in the company, plus an option to acquire all of Quest after 12 months. AMO also is expanding its refractive IOL line-up via an April pact to purchase Pfizer's surgical ophthalmology business...